재택의료 시장 보고서 : 제품별, 서비스별, 적응증별, 지역별(2025-2033년)

The global home healthcare market size reached USD 424.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 816.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.48% during 2025-2033. Several advancements in medical technology, along with the escalating demand for personalized and cost-effective healthcare services, are among the major factors propelling the market growth.

Home healthcare refers to medical and non-medical services provided to individuals in the comfort of their own homes. It assists individuals who may be recovering from an illness, injury, or surgery, managing chronic conditions, or facing challenges due to age-related issues. It typically includes skilled nursing care, physical and occupational therapy, medication management, wound care, and assistance with daily living activities such as bathing, dressing, and meal preparation. It promotes independence and improve the quality of life for patients and allows them to remain in familiar surroundings while receiving personalized and attentive care. Additionally, home healthcare is cost-effective and convenient option and are customized to meet individual needs, ensuring optimal support and a higher level of patient satisfaction.

The market is primarily driven by the growing incidences of chronic ailments. Additionally, the increasing population and the growing geriatric populations susceptible to several diseases prefer to receive medical care and assistance in the comfort of their homes, thus escalating the demand for personalized and continuous healthcare services at home. Moreover, numerous technological advancements in medical technology and telehealth solutions made it easier for healthcare providers to remotely monitor and manage patients in their homes represents another major growth-inducing factor. Besides this, home healthcare offers cost-effective solutions by reducing hospital readmissions and easing the burden on healthcare facilities, thus accelerating the market growth. Along with this, the recent onset of the coronavirus disease (COVID-19) pandemic accelerated the adoption of home-based care, due to social distancing norms, minimizes exposure risks, and ensures safety thus propelling the market growth.

Home Healthcare Market Trends/Drivers:

The prevalence of chronic ailments

The prevalence of chronic diseases such as diabetes, heart disease, chronic respiratory conditions, and neurological disorders, are becoming increasingly common across the globe. These conditions often require long-term management, frequent monitoring, and personalized care, thus influencing market growth. Moreover, home healthcare services are well-suited to address the needs of patients with chronic diseases by receiving care at home, patients can benefit from continuous monitoring, medication management, and support with activities of daily living which represents another major growth-inducing factor. It also offers personalized treatment plans, rehabilitation services, and education to help patients manage their conditions effectively, thus accelerating market growth. Besides this, it can reduce the burden on hospitals and healthcare facilities, as patients with chronic diseases often require frequent follow-up visits and ongoing support, thus augmenting the market growth. Also, by providing care at home, healthcare resources can be better allocated to patients with acute and critical conditions which is propelling the market growth. Furthermore, the shift toward home-based care improves patient outcomes and quality of life and contributes to cost containment and more efficient healthcare delivery, creating a positive market outlook.

Several advancements in medical technologies

The increasing advancements in medical technology are significantly impacting the home healthcare market, transforming the way healthcare services are delivered to patients at their homes. Additionally, the widespread adoption of remote monitoring devices allow healthcare providers to track patients' vital signs, such as blood pressure, heart rate, and blood glucose levels, from a distance, allows timely interventions and better management of chronic conditions, thus influencing the market growth. Moreover, the integration of the Internet of Things (IoT) devices, such as smart pill dispensers, smart beds, and remote-controlled medical equipment, enhance patient safety and convenience, ensuring adherence to treatment plans and reducing the risk of adverse events, represents another major growth-inducing factor. Besides this, the increasing digitization of patient records allows seamless sharing of medical information between healthcare providers, enhancing care coordination and enabling a holistic view of the patient's health history, thus accelerating market growth.

The implementation of favorable government policies

The governments are transforming the potential benefits of home-based care and introducing supportive policies to promote its adoption. Additionally, numerous governments are providing financial incentives and subsidies to healthcare providers and agencies offering home healthcare services to encourage the expansion of home-based care and to improve access for patients, especially in underserved areas, which are influencing the market growth. Moreover, governments are easing regulatory barriers and licensing requirements for home healthcare providers, making it easier for them to operate and offer their services facilitating the entry of new players into the market, representing another major growth-inducing factor. Besides this, the healthcare reimbursement policies are revised to include coverage for home healthcare services, making it more affordable for patients, which is accelerating the demand for home healthcare, particularly among the geriatric population and those with chronic conditions is propelling the market growth.

Home Healthcare Industry Segmentation:

Breakup by Product:

Therapeutic Products

Testing, Screening, and Monitoring Products

Mobility Care Products

Therapeutic products represent the most popular product

Therapeutic products encompass several medical devices, equipment, and supplies designed to aid in the treatment and management of various health conditions at home. These products include mobility aids such as wheelchairs and walking aids, respiratory devices such as oxygen concentrators and nebulizers, and wound care products including dressings and wound healing agents, thus influencing the market growth. Additionally, therapeutic monitoring devices, such as blood glucose meters and blood pressure monitors, are essential in managing chronic conditions and promoting proactive health management, thus augmenting the market growth.

Moreover, advancements in therapeutic product technology have led to user-friendly designs, portability, and increased effectiveness, further fueling their popularity among patients and caregivers representing another major growth-inducing factor. Besides this, the growing geriatric population and prevalence of chronic diseases are accelerating the adoption of therapeutic products, ensuring improved patient outcomes and better quality of life. Along with this, the inclination toward therapeutic products due to their ability to empower patients with greater independence and control over their healthcare, and offer patients with essential medical care without the need for frequent visits to healthcare facilities are propelling the market growth.

Breakup by Service:

Skilled Nursing

Rehabilitation Therapy

Hospice & Palliative Care

Unskilled Care

Respiratory Therapy

Infusion Therapy

Pregnancy Care

Skilled nursing holds the largest share of the market

Skilled nursing is emerging as the dominant service in the home healthcare market. This specialized form of care is provided by trained and licensed nurses who offer comprehensive medical support to patients in the comfort of their homes. It encompasses several healthcare tasks, including wound care, medication management, intravenous therapy, and post-surgical care, thus influencing the market growth.

Additionally, the growing geriatric population and the rising prevalence of chronic illnesses is escalating the demand for skilled nursing services, as patients with complex medical conditions seek personalized and continuous care, thus accelerating the market growth. Also, skilled nursing at home allows patients to avoid hospital stays and reduce the risk of infections, while also providing convenience and comfort during their recovery process.

Breakup by Indication:

Cancer

Respiratory Diseases

Movement Disorders

Cardiovascular Diseases & Hypertension

Pregnancy

Wound Care

Diabetes

Hearing Disorders

Others

Diabetes presently accounts for the largest market share

Diabetes is emerging as a dominant indication driving the growth of the home healthcare market. Additionally, the increasing incidences of diabetes are escalating the demand for home-based care for diabetic patients, thus influencing market growth. Managing diabetes requires continuous monitoring of blood glucose levels, medication adherence, lifestyle modifications, and regular follow-up with healthcare professionals. Home healthcare offers a convenient and personalized approach to address these needs.

Home-based diabetes care enables patients to receive timely interventions, education, and support in the comfort of their homes, leading to improved disease management and patient outcomes. Additionally, several advancements in medical technology, such as glucose monitoring devices and telehealth solutions, further facilitate remote monitoring and consultation, enhancing the effectiveness of home-based diabetes care. Furthermore, the cost-effectiveness for diabetic patients is particularly appealing, as it reduces the burden on healthcare facilities and minimizes hospital readmissions.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is currently dominating the home healthcare market, holding the largest share due to the growing geriatric population, rising prevalence of chronic diseases, and advanced healthcare infrastructure driving the demand for home-based healthcare services. Additionally, technological advancements in medical devices and telehealth solutions is further accelerating the adoption of home healthcare in North America.

In Europe, the market is experiencing significant growth due to the growing geriatric population, and the increasing healthcare costs leading to governments and healthcare providers to focus on home-based care as a cost-effective and patient-centric solution. Furthermore, favourable government policies and reimbursement support are encouraging the expansion of home healthcare services across Europe.

The Asia Pacific market is witnessing rapid growth due to its growing population, rising awareness of home-based care options, improving healthcare infrastructure, and an increase in chronic diseases, which are escalating the demand for accessible and personalized healthcare services at home.

Competitive Landscape:

Nowadays, key players in the home healthcare market are implementing several strategies to strengthen their position and maintain a competitive edge. They are expanding their range of services to cater to a broader spectrum of patient needs including offering a comprehensive suite of medical, nursing, rehabilitation, and personal care services at home. Moreover, key players are investing in advanced medical technology, remote monitoring devices, telehealth platforms, and mobile health applications to enhance the quality of care, improve patient outcomes, and facilitate remote consultations. Besides this, several companies are prioritizing patient-centric care by customizing services to individual needs, providing personalized treatment plans, and actively involving patients and their families in care decisions. Furthermore, key players are building a robust network of skilled healthcare professionals, including nurses, therapists, and caregivers, to ensure seamless and efficient delivery of services. They are also establishing a strong brand identity and implementing effective marketing strategies to help companies create awareness, build reputation, and attract new patients.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

A&D Company Limited

Addus HomeCare Corporation

Amedisys Inc.

B. Braun Melsungen AG

Baxter International Inc.

Becton Dickinson and Company

Fresenius Medical Care AG & Co. KGaA

Invacare Corporation

Koninklijke Philips N.V.

McKesson Corporation

Medline Industries LP

OMRON Healthcare Inc. (Omron Corporation) and ResMed Inc.

Key Questions Answered in This Report:

• How has the global home healthcare market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global home healthcare market?
• What is the impact of each driver, restraint, and opportunity on the global home healthcare market growth?
• What are the key regional markets?
• Which countries represent the most attractive home healthcare market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the home healthcare market?
• What is the breakup of the market based on the service?
• Which is the most attractive service in the home healthcare market?
• What is the breakup of the market based on the indication?
• Which is the most attractive indication in the home healthcare market?
• What is the competitive structure of the global home healthcare market?
• Who are the key players/companies in the global home healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Home Healthcare Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Therapeutic Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Testing, Screening, and Monitoring Products
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Mobility Care Products
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Service

• 7.1 Skilled Nursing
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Rehabilitation Therapy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Hospice & Palliative Care
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Unskilled Care
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Respiratory Therapy
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Infusion Therapy
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Pregnancy Care
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast

8 Market Breakup by Indication

• 8.1 Cancer
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Respiratory Diseases
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Movement Disorders
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Cardiovascular Diseases & Hypertension
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Pregnancy
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Wound Care
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Diabetes
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast
• 8.8 Hearing Disorders
  • 8.8.1 Market Trends
  • 8.8.2 Market Forecast
• 8.9 Others
  • 8.9.1 Market Trends
  • 8.9.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 A&D Company Limited
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Addus HomeCare Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Amedisys Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 B. Braun Melsungen AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Baxter International Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Becton Dickinson and Company
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Fresenius Medical Care AG & Co. KGaA
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Invacare Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Koninklijke Philips N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 McKesson Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Medline Industries LP
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 SWOT Analysis
  • 14.3.12 OMRON Healthcare Inc. (Omron Corporation)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 SWOT Analysis
  • 14.3.13 ResMed Inc.
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report